401 related articles for article (PubMed ID: 24442106)
1. Smoking, p53 mutation, and lung cancer.
Gibbons DL; Byers LA; Kurie JM
Mol Cancer Res; 2014 Jan; 12(1):3-13. PubMed ID: 24442106
[TBL] [Abstract][Full Text] [Related]
2. Molecular alterations and lung tumors in p53 mutant mice exposed to cigarette smoke.
De Flora S; Balansky RM; D'Agostini F; Izzotti A; Camoirano A; Bennicelli C; Zhang Z; Wang Y; Lubet RA; You M
Cancer Res; 2003 Feb; 63(4):793-800. PubMed ID: 12591728
[TBL] [Abstract][Full Text] [Related]
3. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT
Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258
[TBL] [Abstract][Full Text] [Related]
4. Clinical implication of p53 mutation in lung cancer.
Campling BG; El-Deiry WS
Mol Biotechnol; 2003 Jun; 24(2):141-56. PubMed ID: 12746555
[TBL] [Abstract][Full Text] [Related]
5. A small-cell lung cancer genome with complex signatures of tobacco exposure.
Pleasance ED; Stephens PJ; O'Meara S; McBride DJ; Meynert A; Jones D; Lin ML; Beare D; Lau KW; Greenman C; Varela I; Nik-Zainal S; Davies HR; Ordoñez GR; Mudie LJ; Latimer C; Edkins S; Stebbings L; Chen L; Jia M; Leroy C; Marshall J; Menzies A; Butler A; Teague JW; Mangion J; Sun YA; McLaughlin SF; Peckham HE; Tsung EF; Costa GL; Lee CC; Minna JD; Gazdar A; Birney E; Rhodes MD; McKernan KJ; Stratton MR; Futreal PA; Campbell PJ
Nature; 2010 Jan; 463(7278):184-90. PubMed ID: 20016488
[TBL] [Abstract][Full Text] [Related]
6. Lung-Enriched Mutations in the p53 Tumor Suppressor: A Paradigm for Tissue-Specific Gain of Oncogenic Function.
Barta JA; McMahon SB
Mol Cancer Res; 2019 Jan; 17(1):3-9. PubMed ID: 30224539
[TBL] [Abstract][Full Text] [Related]
7. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers.
Pfeifer GP; Denissenko MF; Olivier M; Tretyakova N; Hecht SS; Hainaut P
Oncogene; 2002 Oct; 21(48):7435-51. PubMed ID: 12379884
[TBL] [Abstract][Full Text] [Related]
8. On the origin of p53 G:C --> T:A transversions in lung cancers.
Rodin SN; Rodin AS
Mutat Res; 2002 Oct; 508(1-2):1-19. PubMed ID: 12379456
[TBL] [Abstract][Full Text] [Related]
9. Tobacco smoke-induced lung tumorigenesis in mutant A/J mice with alterations in K-ras, p53, or Ink4a/Arf.
Wang Y; Zhang Z; Lubet R; You M
Oncogene; 2005 Apr; 24(18):3042-9. PubMed ID: 15846305
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk.
Hwang SJ; Cheng LS; Lozano G; Amos CI; Gu X; Strong LC
Hum Genet; 2003 Aug; 113(3):238-43. PubMed ID: 12802680
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of p53 mutations in lung cancer.
Campling BG; el-Deiry WS
Methods Mol Med; 2003; 75():53-77. PubMed ID: 12407735
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity is related to p53 mutations and smoking in lung cancer.
Zienolddiny S; Ryberg D; Arab MO; Skaug V; Haugen A
Br J Cancer; 2001 Jan; 84(2):226-31. PubMed ID: 11161381
[TBL] [Abstract][Full Text] [Related]
13. [The p53 gene and protein in bronchial carcinogenesis:from biological to clinical aspects].
Zalcman G; Trédaniel J; Lechapt E; Lubin R; Soussi T; Hirsch A
Rev Mal Respir; 1994; 11(5):455-72. PubMed ID: 7816989
[TBL] [Abstract][Full Text] [Related]
14. Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair.
Feng Z; Hu W; Hu Y; Tang MS
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15404-9. PubMed ID: 17030796
[TBL] [Abstract][Full Text] [Related]
15. Tobacco smoke carcinogens and lung cancer.
Hecht SS
J Natl Cancer Inst; 1999 Jul; 91(14):1194-210. PubMed ID: 10413421
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the P53 tumour suppressor gene in primary lung cancer in Japan.
Kondo K; Umemoto A; Akimoto S; Uyama T; Hayashi K; Ohnishi Y; Monden Y
Biochem Biophys Res Commun; 1992 Mar; 183(3):1139-46. PubMed ID: 1348931
[TBL] [Abstract][Full Text] [Related]
17. Origins and selection of p53 mutations in lung carcinogenesis.
Rodin SN; Rodin AS
Semin Cancer Biol; 2005 Apr; 15(2):103-12. PubMed ID: 15652455
[TBL] [Abstract][Full Text] [Related]
18. p53 mutations in lung cancer following radiation therapy for Hodgkin's disease.
De Benedetti VM; Travis LB; Welsh JA; van Leeuwen FE; Stovall M; Clarke EA; Boice JD; Bennett WP
Cancer Epidemiol Biomarkers Prev; 1996 Feb; 5(2):93-8. PubMed ID: 8850268
[TBL] [Abstract][Full Text] [Related]
19. On the excess of G --> T transversions in the p53 gene in lung cancer cell lines. Reply to Pfeifer and Hainaut.
Rodin SN; Rodin AS
Mutat Res; 2004 Jan; 545(1-2):141-4; author reply 145-6; discussion 147. PubMed ID: 14698424
[TBL] [Abstract][Full Text] [Related]
20. Combined effects of asbestos and cigarette smoke on the development of lung adenocarcinoma: different carcinogens may cause different genomic changes.
Inamura K; Ninomiya H; Nomura K; Tsuchiya E; Satoh Y; Okumura S; Nakagawa K; Takata A; Kohyama N; Ishikawa Y
Oncol Rep; 2014 Aug; 32(2):475-82. PubMed ID: 24926563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
